Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecan

Philip He, Dhiraj Gambhire, Haiming Zhou, Xiaoyang Ma, Yoshihiro Emura, Abderrahmane Laadem, David Leung, Susan Bates, Antonio Tito Fojo, Olivier Rixe

Open source

DOI
10.1093/oncolo/oyaf057
Published
2025-05
Container
The Oncologist
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyaf057,
  title = {Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecan},
  author = {Philip He and Dhiraj Gambhire and Haiming Zhou and Xiaoyang Ma and Yoshihiro Emura and Abderrahmane Laadem and David Leung and Susan Bates and Antonio Tito Fojo and Olivier Rixe},
  year = {2025},
  journal = {The Oncologist},
  doi = {10.1093/oncolo/oyaf057},
  url = {https://doi.org/10.1093/oncolo/oyaf057}
}

RIS

TY  - JOUR
TI  - Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecan
AU  - Philip He
AU  - Dhiraj Gambhire
AU  - Haiming Zhou
AU  - Xiaoyang Ma
AU  - Yoshihiro Emura
AU  - Abderrahmane Laadem
AU  - David Leung
AU  - Susan Bates
AU  - Antonio Tito Fojo
AU  - Olivier Rixe
PY  - 2025
JO  - The Oncologist
DO  - 10.1093/oncolo/oyaf057
UR  - https://doi.org/10.1093/oncolo/oyaf057
ER  - 

APA

He, P., Gambhire, D., Zhou, H., Ma, X., Emura, Y., Laadem, A., Leung, D., Bates, S., Fojo, A. T., & Rixe, O. (2025). Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecan. The Oncologist. https://doi.org/10.1093/oncolo/oyaf057

Source records